Bloomberg Podcasts
@bloombergpodcasts·503K subscribers·32.4K videos
Monte Dei Paschi Up, Tate & Lyle Out, Zealand Pharma Down | Stock Movers
Posted
June 8, 2026
Views
179
Likes
2
Engagement
1.12%
June 8, 2026
179
2
1.12%
Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
4:35Now PlayingToday's biggest winners and losers in the stock market.
On this episode of Stock Movers:
- Intesa Sanpaolo offered to buy Banca Monte dei Paschi di Siena for €30.6 billion ($35.3 billion) in a move that’s set to spur a new phase of dealmaking in Italian finance.
- Ingredion agreed to buy Tate & Lyle Plc for £2.7 billion ($3.6 billion), in a move that marks the end of the UK company’s near-century on the London Stock Exchange.
- Zealand Pharma shares tumbled after new data on two experimental obesity drugs fueled concerns about their ability to compete in an increasingly crowded weight-loss market.
See omnystudio.com/listener () for privacy information.
Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for analysis on the companies making news on Wall Street.
Check out more episodes of Stock Movers
Follow Bloomberg Podcasts on Twitter
Visit our other YouTube channels:
Bloomberg Television
Bloomberg Originals
For coverage on news, markets and more
#Stocks #Markets #Finance #Investing #Podcast #Bloomberg
Monte Dei Paschi Up, Tate & Lyle Out, Zealand Pharma Down
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.
